These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26937410)

  • 1. Two consecutive partial liver transplants in a patient with Classic Maple Syrup Urine Disease.
    Chin HL; Aw MM; Quak SH; Huang J; Hart CE; Prabhakaran K; Goh DL
    Mol Genet Metab Rep; 2015 Sep; 4():49-52. PubMed ID: 26937410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Living related versus deceased donor liver transplantation for maple syrup urine disease.
    Feier F; Schwartz IV; Benkert AR; Seda Neto J; Miura I; Chapchap P; da Fonseca EA; Vieira S; Zanotelli ML; Pinto e Vairo F; Camelo JS; Margutti AV; Mazariegos GV; Puffenberger EG; Strauss KA
    Mol Genet Metab; 2016 Mar; 117(3):336-43. PubMed ID: 26786177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the branched-chain alpha-ketoacid dehydrogenase and elucidation of a molecular basis for maple syrup urine disease.
    Harris RA; Zhang B; Goodwin GW; Kuntz MJ; Shimomura Y; Rougraff P; Dexter P; Zhao Y; Gibson R; Crabb DW
    Adv Enzyme Regul; 1990; 30():245-63. PubMed ID: 2403034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemodialysis is an effective treatment in acute metabolic decompensation of maple syrup urine disease.
    Atwal PS; Macmurdo C; Grimm PC
    Mol Genet Metab Rep; 2015 Sep; 4():46-8. PubMed ID: 26937409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Living donor liver transplantation in maple syrup urine disease - Case series and world's youngest domino liver donor and recipient.
    Mohan N; Karkra S; Rastogi A; Vohra V; Soin AS
    Pediatr Transplant; 2016 May; 20(3):395-400. PubMed ID: 26869348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maple syrup urine disease: mechanisms and management.
    Blackburn PR; Gass JM; Vairo FPE; Farnham KM; Atwal HK; Macklin S; Klee EW; Atwal PS
    Appl Clin Genet; 2017; 10():57-66. PubMed ID: 28919799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maple syrup urine disease decompensation misdiagnosed as a psychotic event.
    Higashimoto T; Whitehead MT; MacLeod E; Starin D; Regier DS
    Mol Genet Metab Rep; 2022 Sep; 32():100886. PubMed ID: 35756860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease.
    Zinnanti WJ; Lazovic J; Griffin K; Skvorak KJ; Paul HS; Homanics GE; Bewley MC; Cheng KC; Lanoue KF; Flanagan JM
    Brain; 2009 Apr; 132(Pt 4):903-18. PubMed ID: 19293241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma amino acid and urine organic acid profiles of Filipino patients with maple syrup urine disease (MSUD) and correlation with their neurologic features.
    Chiong MA; Tan MA; Cordero CP; Fodra EG; Manliguis JS; Lopez CP; Dalmacio LM
    Mol Genet Metab Rep; 2016 Dec; 9():46-53. PubMed ID: 27761412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine.
    Riazi R; Rafii M; Clarke JT; Wykes LJ; Ball RO; Pencharz PB
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E142-9. PubMed ID: 14970005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging in classic form of maple syrup urine disease: a rare metabolic central nervous system.
    Jain A; Jagdeesh K; Mane R; Singla S
    J Clin Neonatol; 2013 Apr; 2(2):98-100. PubMed ID: 24049754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain Branched-Chain Amino Acids in Maple Syrup Urine Disease: Implications for Neurological Disorders.
    Xu J; Jakher Y; Ahrens-Nicklas RC
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid changes in the metabolome of a single case study with maple syrup urine disease (MSUD) after five days of improved diet adherence of controlled branched-chain amino acids (BCAA).
    Douglas TD; Newby LK; Eckstrand J; Wixted D; Singh RH
    Mol Genet Metab Rep; 2020 Dec; 25():100651. PubMed ID: 33088714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Domino liver transplantation in maple syrup urine disease.
    Khanna A; Hart M; Nyhan WL; Hassanein T; Panyard-Davis J; Barshop BA
    Liver Transpl; 2006 May; 12(5):876-82. PubMed ID: 16628687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Metabolic Crises in Maple Syrup Urine Disease After Liver Transplantation from a Related Heterozygous Living Donor.
    Al-Shamsi A; Baker A; Dhawan A; Hertecant J
    JIMD Rep; 2016; 30():59-62. PubMed ID: 27117295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and characterization of murine models of classic and intermediate maple syrup urine disease.
    Homanics GE; Skvorak K; Ferguson C; Watkins S; Paul HS
    BMC Med Genet; 2006 Mar; 7():33. PubMed ID: 16579849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver transplantation in maple syrup urine disease.
    Wendel U; Saudubray JM; Bodner A; Schadewaldt P
    Eur J Pediatr; 1999 Dec; 158 Suppl 2():S60-4. PubMed ID: 10603101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous administration of a branched-chain amino-acid-free solution in children and adults with acute decompensation of maple syrup urine disease: a prospective multicentre observational study.
    Alili JM; Berleur MP; Husson MC; Mention K; Schiff M; Arnoux JB; Brassier A; Guemman AS; Grisel C; Dubois S; Abi-Wardé MT; Broissand C; Servais A; Dao M; de Lonlay P
    Orphanet J Rare Dis; 2022 May; 17(1):202. PubMed ID: 35578286
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.